These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

999 related articles for article (PubMed ID: 34897520)

  • 1. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
    Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
    Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive correlation between inflammation on sacroiliac joint MRI and serum C-terminal telopeptide of type-I collagen in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis.
    Kang KY; Jung JY; Hong YS; Ju JH; Park SH
    Clin Exp Rheumatol; 2017; 35(3):415-422. PubMed ID: 27974096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium of Canada scoring system.
    Zhang Y; Guo Z; Zhan Y; Qu J; Lei X
    BMC Musculoskelet Disord; 2022 Jul; 23(1):654. PubMed ID: 35804360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
    Tsang HHL; Chung HY
    J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in MRI in patients with spondyloarthritis treated with anti-TNF agents: systematic review of the literature and meta-analysis.
    Khoury G; Combe B; Morel J; Lukas C
    Clin Exp Rheumatol; 2021; 39(2):242-252. PubMed ID: 33506749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis.
    Rudwaleit M; Marzo-Ortega H; Navarro-Compán V; Tham R; Kumke T; Bauer L; de Peyrecave N; Kim M; Van den Bosch F
    RMD Open; 2024 Aug; 10(3):. PubMed ID: 39209369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial.
    van der Heijde D; Baraliakos X; Hermann KA; Landewé RBM; Machado PM; Maksymowych WP; Davies OR; de Peyrecave N; Hoepken B; Bauer L; Nurminen T; Braun J
    Ann Rheum Dis; 2018 May; 77(5):699-705. PubMed ID: 29343510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of macrophage-associated chemokines in the assessment of initial axial spondyloarthritis.
    Li X; Liang A; Cui Y; Liao J; Fang X; Zhong S
    Clin Rheumatol; 2022 Nov; 41(11):3383-3389. PubMed ID: 35882716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.
    Protopopov M; Sieper J; Haibel H; Listing J; Rudwaleit M; Poddubnyy D
    Arthritis Res Ther; 2017 Oct; 19(1):240. PubMed ID: 29065931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
    Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
    Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of sacroiliac joint MRI and added value of spine MRI to detect active spondyloarthritis.
    Plier M; Nzeusseu Toukap A; Michoux N; Stoenoiu MS; Kirchgesner T; Durez P; Lauwerys B; Lecouvet FE
    Diagn Interv Imaging; 2021 Mar; 102(3):171-180. PubMed ID: 32830083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis.
    Braun J; Blanco R; Marzo-Ortega H; Gensler LS; Van den Bosch F; Hall S; Kameda H; Poddubnyy D; van de Sande M; van der Heijde D; Zhuang T; Stefanska A; Readie A; Richards HB; Deodhar A
    Arthritis Res Ther; 2023 May; 25(1):80. PubMed ID: 37194094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active Inflammatory and Chronic Structural Damages of Sacroiliac Joint in Patients With Radiographic Axial Spondyloarthritis and Non-Radiographic Axial Spondyloarthritis.
    Tu L; Lin C; Xie Y; Wang X; Wei Q; Zhang Y; Gu J
    Front Immunol; 2021; 12():700260. PubMed ID: 34386008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of SPARCC sacroiliac MRI scoring in axial psoriatic arthritis and its association with other disease parameters.
    Gezer HH; Duruöz MT
    Int J Rheum Dis; 2022 Apr; 25(4):433-439. PubMed ID: 35080124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis and imaging progression in early axial spondyloarthritis: results from a 48-month follow-up (Italian arm of SPACE study).
    Lorenzin M; Ortolan A; Vio S; Cozzi G; Scapin V; De Conti G; Doria A; Ramonda R
    Rheumatology (Oxford); 2022 May; 61(6):2375-2387. PubMed ID: 34605894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spine and sacroiliac joints on magnetic resonance imaging in patients with early axial spondyloarthritis: prevalence of lesions and association with clinical and disease activity indices from the Italian group of the SPACE study.
    Lorenzin M; Ortolan A; Frallonardo P; Vio S; Lacognata C; Oliviero F; Punzi L; Ramonda R
    Reumatismo; 2016 Sep; 68(2):72-82. PubMed ID: 27608795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI.
    Althoff CE; Sieper J; Song IH; Haibel H; Weiß A; Diekhoff T; Rudwaleit M; Freundlich B; Hamm B; Hermann KG
    Ann Rheum Dis; 2013 Jun; 72(6):967-73. PubMed ID: 22736088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI evidence of structural changes in the sacroiliac joints of patients with non-radiographic axial spondyloarthritis even in the absence of MRI inflammation.
    Maksymowych WP; Wichuk S; Dougados M; Jones H; Szumski A; Bukowski JF; Marshall L; Lambert RG
    Arthritis Res Ther; 2017 Jun; 19(1):126. PubMed ID: 28587658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacroiliac and spine imaging in spondyloarthritis: Does phenotype or sex matter?
    Pereira GC; Machado NP; Gomes AF; Assad RL; Carneiro FH; Azevedo VF
    Adv Rheumatol; 2024 Sep; 64(1):68. PubMed ID: 39256831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.